Douglas Carsten > McDermott Will & Emery LLP > Irvine, United States > Lawyer Profile
McDermott Will & Emery LLP Offices

18565 JAMBOREE ROAD
SUITE 250
IRVINE, CA 92612
CALIFORNIA
United States
- Firm Profile
- Go to...
Douglas Carsten

Work Department
Intellectual Property
Position
Douglas (Doug) H. Carsten is the co-head of McDermott’s global Intellectual Property Group and focuses his practice on complex patent litigation disputes. He counsels clients in various technology areas, including pharmaceuticals, biologics, medical devices, diagnostic products, retail products, and computer software. Doug has substantial first-chair trial experience that includes litigating high-profile and billion-dollar patent cases.
Please visit McDermott website for full biography: https://www.mwe.com/people/carsten-douglas-h/
Lawyer Rankings
United States > Intellectual property > Patents: litigation (full coverage)
Fielding a team of ‘experts in multiple patent lawsuits in pharmaceutical field‘, McDermott Will & Emery LLP represents global and domestic clients in patent litigation across industry sectors, with particular emphasis on the life sciences space. William Gaede in San Francisco leads the global intellectual property practice and acts for biotech, pharma, and medical device companies. Patent litigator Douglas Carsten in Orange County is a life sciences expert, Boston-based IP attorney Sarah Columbia works across the pharma and tech sectors, and Michael Chu in Chicago has a broad IP practice. The group also includes IP litigators Thomas Steindler in Washington DC, Shane Nichols in Atlanta, and Kevin Meek in Austin, and New-York based lawyer Simon Roberts, who handles patent infringement cases for major pharma companies.
United States > Healthcare > Life sciences
One client suggests that McDermott Will & Emery LLP fields ‘best trial team in the patent litigation space,’ and the practice is sought after by clients seeking both to protect their novel drugs and enforce them in the face of infringements. Beyond this, the firm is able to provide support across myriad matters, including stock and asset deals, M&As and partnerships in the industry. Jointly leading the team alongside her are Douglas Carsten, an Orange County-based specialist in life sciences patent disputes who helps clients protect pharmaceuticals, biologics and medical devices, and Silicon Valley’s William Gaede, a fellow patent litigator who specializes in antibodies, proteins and small molecules. Also in Silicon Valley, Bhanu Sadasivan litigates patent disputes concerning recombinant DNA technology. Vernessa Pollard and Anisa Mohanty departed the firm in February 2024.
Lawyer Rankings
- Life sciences United States > Healthcare
- Patents: litigation (full coverage) United States > Intellectual property
Top Tier Firm Rankings
- Media, technology and telecoms > Technology transactions
- Healthcare > Health insurers
- Healthcare > Life sciences
- Media, technology and telecoms > Outsourcing
- Healthcare > Service providers
- Tax > US taxes: contentious
- Tax > US taxes: non-contentious
Firm Rankings
- Labor and employment > Employee benefits, executive compensation and retirement plans: design
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Energy > Energy regulation: electric power
- Tax > Financial products
- Labor and employment > Immigration
- Tax > International tax
- M&A/corporate and commercial > M&A: middle-market ($500m-999m)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Energy > Renewable/alternative power
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- Labor and employment > Workplace and employment counseling
- Insurance > Advice to insurers
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Labor and employment > ERISA litigation
- Dispute resolution > General commercial disputes
- Insurance > Insurance: non-contentious
- Labor and employment > Labor and employment disputes (including collective actions)
- Labor and employment > Labor-management relations
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- Real estate > Real estate finance
- Finance > Capital markets: equity offerings
- Antitrust > Cartel
- Antitrust > Civil litigation/class actions: defense
- Energy > Energy transactions: electric power
- Energy > Energy transactions: oil and gas
- Government > Government contracts
- Antitrust > Merger control
- Intellectual property > Patents: litigation (full coverage)
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Securities litigation: defense
- Finance > Structured finance: derivatives and structured products
- International trade and national security > Trade remedies and trade policy
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Dispute resolution > International arbitration
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Investment fund formation and management > Private equity funds (including venture capital)
- Real estate > Real estate
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Commercial lending
- Finance > Fintech